FIELD: medicine; pharmaceuticals; medicine.
SUBSTANCE: group of inventions refers to pharmacy, veterinary science and medicine. Disclosed is use of a pharmaceutical composition for preventing and/or treating central nervous system tissue disorders caused by a cerebral hypoxic pathological condition, wherein said composition contains a biocompatible polymer (particularly OTR4131) and a mesenchymal stem cell; disclosed is use of said composition for preparing a medicament for the same purpose.
EFFECT: technical result consists in reducing the extent of cerebral infarction and improving functional recovery and preservation of vascular tissue.
4 cl, 7 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS FOR TREATING TISSUE INJURIES | 2016 |
|
RU2721116C2 |
| HEPARAN SULPHATES | 2013 |
|
RU2700877C2 |
| EXTRACELLULAR VESICLES ORIGINATING FROM MESENCHYMAL STEM CELLS | 2019 |
|
RU2805066C2 |
| METHOD OF TREATING INFECTIOUS PERITONITIS EXPERIMENTALLY | 2014 |
|
RU2553342C1 |
| CELL-FREE THERAPEUTIC AGENTS FOR REGENERATIVE MEDICINE AND METHODS FOR PREPARING THEM | 2018 |
|
RU2742034C2 |
| CELL-BASED THERAPY OF ISCHEMIC TISSUE | 2009 |
|
RU2535966C2 |
| METHOD OF OBTAINING AND USING MESENCHYMAL STEM CELL SPHEROIDS FOR; TREATMENT OF SKIN INJURIES | 2022 |
|
RU2812015C1 |
| MARROW STROMAL CELL MATERIAL FOR APPLICATION IN BLOOD VESSEL FORMATION AND GENERATION OF ANGIOGENETIC AND TROPHIC FACTORS | 2003 |
|
RU2332223C2 |
| METHOD FOR STIMULATING SPINAL CORD REGENERATION BY MESENCHYMAL STEM CELLS, WHICH ARE INCLUDED IN THE FIBRIN MATRIX | 2016 |
|
RU2650638C1 |
| USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) | 2017 |
|
RU2742828C2 |
